FDA Just Approved a New Blue Food Dye
Digest more
And Go Concepts LLC announced a voluntary recall for a range of vegetable products on May 27 due to potential listeria contamination.
MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet issue for Commissioner Marty Makary that’s separately garnered attention in the states and on social media.
The U.S. Food and Drug Administration's staff reviewers on Tuesday raised safety concerns that GSK's blood cancer drug Blenrep, when used in combination with other treatments, may cause eye damage in patients.
Kratom, made from the leaves of a tropical tree called Mitragyna speciosa that is native to Southeast Asia, contains two main chemical components: mitragynine and 7-hydroxymitragynine. The University of Florida College of Pharmacy says that kratom products should contain no more than 66% mitragynine as the main alkaloid and 2% 7-hydroxymitragynine.
Coalition Urges Stronger FDA Front-of-Package Labels on Sugars, Sodium, Fats 28 consumer and health groups plus 12 researchers back mandatory nutritio
Explore more
According to Makary, reducing user fees—which make up just under half of the FDA's budget—could make it easier for smaller companies, individual investors and academics to participate in the process.
Arexvy is currently approved to prevent lower respiratory tract disease (LRTD) caused by RSV in individuals aged 60 years and older, and those 50 to 59 years of age who are at increased risk for LRTD caused by RSV.
As FDA kicked off the drug user fee reauthorization process, Commissioner Marty Makary said he’d like to see lower fees paid by industry
British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the use of its respiratory syncytial virus (RSV) vaccine to adults under the age of 50 at a higher risk of the disease.